- Home
- SGHT vs ANIK Comparison
SGHT vs ANIK Comparison
Compare SGHT & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- ANIK
- Stock Information
- Founded
- SGHT 2011
- ANIK 1983
- Country
- SGHT United States
- ANIK United States
- Employees
- SGHT 216
- ANIK N/A
- Industry
- SGHT Medical Specialities
- ANIK Medical/Dental Instruments
- Sector
- SGHT Health Care
- ANIK Health Care
- Exchange
- SGHT Nasdaq
- ANIK Nasdaq
- Market Cap
- SGHT 179.7M
- ANIK 196.6M
- IPO Year
- SGHT 2021
- ANIK 1993
- Fundamental
- Price
- SGHT $3.64
- ANIK $11.45
- Analyst Decision
- SGHT Buy
- ANIK Buy
- Analyst Count
- SGHT 8
- ANIK 1
- Target Price
- SGHT $4.01
- ANIK $19.00
- AVG Volume (30 Days)
- SGHT 164.1K
- ANIK 118.5K
- Earning Date
- SGHT 07-31-2025
- ANIK 08-07-2025
- Dividend Yield
- SGHT N/A
- ANIK N/A
- EPS Growth
- SGHT N/A
- ANIK N/A
- EPS
- SGHT N/A
- ANIK N/A
- Revenue
- SGHT $78,109,000.00
- ANIK $117,053,000.00
- Revenue This Year
- SGHT N/A
- ANIK N/A
- Revenue Next Year
- SGHT $11.60
- ANIK $9.70
- P/E Ratio
- SGHT N/A
- ANIK N/A
- Revenue Growth
- SGHT N/A
- ANIK 4.61
- 52 Week Low
- SGHT $2.03
- ANIK $10.47
- 52 Week High
- SGHT $8.45
- ANIK $29.12
- Technical
- Relative Strength Index (RSI)
- SGHT 38.36
- ANIK 50.73
- Support Level
- SGHT $3.37
- ANIK $10.91
- Resistance Level
- SGHT $3.60
- ANIK $11.47
- Average True Range (ATR)
- SGHT 0.23
- ANIK 0.49
- MACD
- SGHT -0.12
- ANIK 0.11
- Stochastic Oscillator
- SGHT 8.21
- ANIK 83.00
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.